The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer

Abstract Background Apatinib is an oral small‐molecule tyrosine kinase inhibitor that blocks vascular endothelial growth factor receptor‐2. Oral vinorelbine is a semisynthetic chemotherapeutic agent of vinorelbine alkaloids. Apatinib and oral vinorelbine have been proved to be effective in the treat...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jia‐Yi Huang, Xue‐Lian Chen, Xiao‐Feng Xie, Lin Song, Li‐Ping Chen, Xiao‐Feng Lan, Xue Bai, Xiao Chen, Cai‐Wen Du
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2024-04-01
Ráidu:	Cancer Medicine
Fáttát:	antiangiogenesis therapy low‐dose apatinib metastatic breast cancer oral vinorelbine
Liŋkkat:	https://doi.org/10.1002/cam4.7181
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!